No abstract available
MeSH terms
-
Chemotherapy, Adjuvant
-
Clinical Trials, Phase III as Topic
-
Colorectal Neoplasms / drug therapy*
-
Colorectal Neoplasms / enzymology
-
Colorectal Neoplasms / mortality
-
Colorectal Neoplasms / pathology
-
Colorectal Neoplasms / surgery
-
Cyclooxygenase 2 / analysis
-
Cyclooxygenase 2 Inhibitors / adverse effects
-
Cyclooxygenase 2 Inhibitors / therapeutic use*
-
Disease-Free Survival
-
Early Termination of Clinical Trials
-
Evidence-Based Medicine
-
Humans
-
Lactones / adverse effects
-
Lactones / therapeutic use*
-
Multicenter Studies as Topic
-
Neoplasm Recurrence, Local
-
Neoplasm Staging
-
Randomized Controlled Trials as Topic
-
Risk Assessment
-
Risk Factors
-
Safety-Based Drug Withdrawals
-
Sulfones / adverse effects
-
Sulfones / therapeutic use*
-
Time Factors
-
Treatment Outcome
Substances
-
Cyclooxygenase 2 Inhibitors
-
Lactones
-
Sulfones
-
rofecoxib
-
Cyclooxygenase 2
-
PTGS2 protein, human